Experimental eye drops tested for autoimmune dry eye disease
NCT ID NCT07192666
Summary
This early-stage trial is testing whether exosome therapy can help improve severe dry eye symptoms in people with Sjögren's syndrome. The study will enroll 12 adults whose eye symptoms haven't improved with standard treatments like artificial tears. Researchers will monitor safety and check if the treatment improves tear production, eye surface health, and comfort over 29 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJÖGREN´S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.